WebNov 29, 2024 · Concordia/ ADVANZ PHARMA is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. Going forward, the Company is focused on helping innovate, shape and grow the specialty, off-patent sector in Europe. WebRegional Director - Americas, Africa, Mena and Asia. ADVANZ PHARMA. Dec 2024 - Aug 20243 years 9 months. London, United Kingdom.
Senior Regional Director ROW - ADVANZ PHARMA
WebNov 29, 2024 · Concordia/ ADVANZ PHARMA is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, … WebJan 13, 2014 · Advanz Pharmaceutical Investors Advanz Pharmaceutical Investors Concordia Healthcare corp. Announces FDA agreement on special protocol assessment for phase 3 clinical trial on new therapy to treat Perihilar Cholangiocarcinoma 13.01.14 Agreement represents continued movement forward in the development of a potential … go away bird sound
Advanz Pharma Corp Company Profile - Dun & Bradstreet
WebAug 9, 2015 · Advanz Pharmaceutical Investors Advanz Pharmaceutical Investors Concordia Healthcare to acquire Amdipharm mercury limited (amco) for us$3.5 billion creating a global platform to facilitate future growth 08.09.15 Positions Concordia as a leading, international specialty pharmaceutical company with commercial reach in over … Advanz Pharma Corp. is a multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2024. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds whic… WebSep 12, 2024 · Concordia is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. Going forward, the Company is focused on becoming a leader in European specialty, off-patent medicines. bone shaped like a butterfly